Abnormal behavior
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Whether variations in ADCY7 and possible variations in other members of this gene family are underlying other psychiatric disorders remains to be studied.
|
9034014 |
1997 |
Acute Myeloid Leukemia (AML-M2)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
|
18206229 |
2008 |
Acute Myeloid Leukemia, M1
|
0.300 |
Biomarker
|
disease |
CTD_human |
Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
|
18206229 |
2008 |
Acute Promyelocytic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our results show that miR-192-mediated AC7 could play important roles in differentiation of APL cells, AC7 and miR-192 might be new biomarkers and therapeutic targets for patients with relapsed APL.
|
30366671 |
2018 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In the human sample, we found that single nucleotide polymorphisms in ADCY7 associate with alcohol dependence in women, and these markers are also associated with ADCY7 expression (messenger RNA) levels.
|
21481845 |
2011 |
Alcoholic Intoxication, Chronic
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
In the human sample, we found that single nucleotide polymorphisms in ADCY7 associate with alcohol dependence in women, and these markers are also associated with ADCY7 expression (messenger RNA) levels.
|
21481845 |
2011 |
Ankylosing spondylitis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Autoimmune Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Autoimmune Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Autoimmune thyroiditis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Celiac Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Childhood Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Our study suggests that inhibition of ADCY7 may be novel strategy for treating leukemia.
|
26220344 |
2015 |
Common Variable Immunodeficiency
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Crohn Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
Depressed mood
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Depressed mood
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Adenylyl cyclase 7 and neuropsychiatric disorders: A new target for depression?
|
30904753 |
2019 |
Depressive disorder
|
0.330 |
Biomarker
|
disease |
BEFREE |
This converging cross-species evidence implicates ADCY7 in the modulation of mood regulatory neural mechanisms and, possibly, risk for and pathophysiology of depression, together supporting a continuous dimensional approach to major depressive disorder and other affective disorders.
|
22264442 |
2012 |
Depressive disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Collectively, our results demonstrate a sex-specific influence of the AC7 gene on a heritable form of depressive illness.
|
17135423 |
2006 |
Depressive disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Collectively, our results demonstrate a sex-specific influence of the AC7 gene on a heritable form of depressive illness.
|
17135423 |
2006 |